自20世纪90年代早期人类第1个黑素瘤分子标记物(或者抗原)鉴定以来,肿瘤免疫专家试图通过提高肿瘤特异性T淋巴细胞数量来治疗黑素瘤。最近Morgan等首次联合疫苗、基因工程、过继细胞转移和细胞因子4种方法治疗黑素瘤,使2名早期治疗失败的转移性黑素瘤患者病情得到控制。因为癌? Since the identification of the first human melanoma molecular marker (or antigen) in the early 1990s, oncology immunologists have sought to treat melanoma by increasing the number of tumor-specific T lymphocytes. Recently, Morgan et al.’s first combination of vaccines, genetic engineering, adoptive cell transfer and cytokine treatment of melanoma resulted in the control of two patients with metastatic melanoma who had failed early treatment. Because of cancer?